JP2025506484A5 - - Google Patents
Info
- Publication number
- JP2025506484A5 JP2025506484A5 JP2024547471A JP2024547471A JP2025506484A5 JP 2025506484 A5 JP2025506484 A5 JP 2025506484A5 JP 2024547471 A JP2024547471 A JP 2024547471A JP 2024547471 A JP2024547471 A JP 2024547471A JP 2025506484 A5 JP2025506484 A5 JP 2025506484A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263309467P | 2022-02-11 | 2022-02-11 | |
| US63/309,467 | 2022-02-11 | ||
| PCT/US2023/012949 WO2023154528A1 (en) | 2022-02-11 | 2023-02-13 | Stereoselective technologies for chiral compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506484A JP2025506484A (ja) | 2025-03-11 |
| JP2025506484A5 true JP2025506484A5 (https=) | 2026-02-24 |
Family
ID=87564999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547471A Pending JP2025506484A (ja) | 2022-02-11 | 2023-02-13 | キラル化合物の立体選択的技術 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250154190A1 (https=) |
| EP (1) | EP4476202A1 (https=) |
| JP (1) | JP2025506484A (https=) |
| CN (1) | CN118660876A (https=) |
| WO (1) | WO2023154528A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2872485T3 (pl) | 2012-07-13 | 2021-05-31 | Wave Life Sciences Ltd. | Asymetryczna grupa pomocnicza |
| BR112016016400A2 (pt) | 2014-01-16 | 2017-10-03 | Wave Life Sciences Ltd | Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos |
| IL320434A (en) | 2015-07-22 | 2025-06-01 | Wave Life Sciences Ltd | Oligonucleotide preparations and methods |
| JP2019520339A (ja) | 2016-06-03 | 2019-07-18 | ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． | オリゴヌクレオチド、その組成物および方法 |
| US11873316B2 (en) | 2016-11-23 | 2024-01-16 | Wave Life Sciences Ltd. | Compositions and methods for phosphoramidite and oligonucleotide synthesis |
| US11718638B2 (en) | 2017-06-21 | 2023-08-08 | Wave Life Sciences Ltd. | Compounds, compositions and methods for synthesis |
| CA3072110A1 (en) | 2017-09-18 | 2019-03-21 | Wave Life Sciences Ltd. | Technologies for oligonucleotide preparation |
| SG11202009877XA (en) | 2018-04-12 | 2020-11-27 | Wave Life Sciences Ltd | Oligonucleotide compositions and methods of use thereof |
| US12391942B2 (en) | 2018-05-11 | 2025-08-19 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| JP2022525541A (ja) | 2019-03-20 | 2022-05-17 | ウェイブ ライフ サイエンシズ リミテッド | オリゴヌクレオチド調製に有用な技術 |
| WO2025213142A2 (en) * | 2024-04-05 | 2025-10-09 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE030465T2 (hu) * | 2009-05-13 | 2017-05-29 | Antivirális vegyületek | |
| PL2872485T3 (pl) * | 2012-07-13 | 2021-05-31 | Wave Life Sciences Ltd. | Asymetryczna grupa pomocnicza |
| LT3710439T (lt) * | 2017-11-15 | 2023-05-10 | Mirati Therapeutics, Inc. | Kras g12c inhibitoriai |
| JP2022513719A (ja) * | 2018-12-06 | 2022-02-09 | ウェイブ ライフ サイエンシズ リミテッド | オリゴヌクレオチド組成物及びその方法 |
-
2023
- 2023-02-13 EP EP23753515.8A patent/EP4476202A1/en active Pending
- 2023-02-13 JP JP2024547471A patent/JP2025506484A/ja active Pending
- 2023-02-13 WO PCT/US2023/012949 patent/WO2023154528A1/en not_active Ceased
- 2023-02-13 CN CN202380020485.8A patent/CN118660876A/zh active Pending
- 2023-02-13 US US18/836,993 patent/US20250154190A1/en active Pending